Migraine Drug Shows Promise as IBS Treatment in Small Trial

By News Health
1 hour Ago

(MedPage Today) — PHOENIX — A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn’t shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce gut pain sensitivity…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118234

Author :

Publish date : 2025-10-30 17:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Expert Warns of Irreparable Damage to Biotech Industry Unless Congress Acts

Hospitals Struggle as Consultant Posts Remain Unfilled

Study Finds Optimal Physical Activity Level for Digestive Cancer Risk

Clinicians Test 'Butt Breathing' in Early Study

CAR-T Therapy Leads to Myasthenia Gravis Improvements

T-Cell Killer Opens New Approach to Rheumatoid Arthritis